Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40200-022-01019-x.pdf
Reference85 articles.
1. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–795.
2. Grewal AS, Beniwal M, Pandita D, Sekhon BS, Lather V. Recent updates on peroxisome proliferator-activated receptor δ agonists for the treatment of metabolic syndrome. Med Chem. 2016;12:3–21.
3. Grewal AS, Sekhon BS, Lather V. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus. Mini Rev Med Chem. 2014;14(7):585–602.
4. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren T, Shan P. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:14790.
5. Alhadramy MS. Diabetes and oral therapies: a review of oral therapies for diabetes mellitus. J Taibah Univ Med Sci. 2016;11(4):317–29.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of small molecule glucokinase activators for the treatment of diabetes based on plants from the traditional Chinese medicine: In silico analysis;Microbial Pathogenesis;2024-10
2. Glucokinase activators and imeglimin: new weaponry in the armamentarium against type 2 diabetes;BMJ Open Diabetes Research & Care;2024-08
3. Phosphoenolpyruvate carboxykinase-1 targeted siRNA promotes wound healing in type 2 diabetic mice by restoring glucose homeostasis;International Journal of Biological Macromolecules;2024-06
4. Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study;Journal of Diabetes;2024-05-23
5. Molecular design and virtual screening of novel heterocyclic derivatives as Glucokinase activators;Turkish Computational and Theoretical Chemistry;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3